We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment China Country Manager

8 Dec 2016 07:00

RNS Number : 2872R
Concepta PLC
08 December 2016
 

8 December 2016

 

Concepta plc ("Concepta" or "the Company")

Appointment of China Country Manager Ahead of myLotus Fertility Product Launch

 

Concepta plc (AIM:CPT), the UK healthcare company targeting the personalised mobile health market with a primary focus on women's fertility, is pleased to announce that it has appointed Kevin Su Wei as its China Country Manager, based in Shanghai, with immediate effect. This appointment is in line with the Company's strategy of launching its myLotus product, targeted at women with unexplained infertility* into its first international market, China, early 2017.

 

Mr Su Wei has over 10 years' sales, distribution and opinion leader management experience in healthcare and specifically women's health. He has held management positions at Merck Millipore, the life sciences division of global healthcare player Millipore corporation and at Inverness Medical (now Alere), a leading innovative global diagnostics company.

 

At Concepta Kevin will build Concepta's distributor network and lead the set up of Concepta's Chinese subsidiary in line with the Company's growth projections. Kevin's past experience in China and with fertility products ideally positions him to build Concepta's brand and product presence in China.

 

Erik Henau, CEO of Concepta says: "We are delighted to welcome Kevin as part of our Chinese division here at Concepta. He brings with him a wealth of experience both in healthcare and specifically the women's healthcare market in China that will be invaluable to Concepta as we look to launch our myLotus fertility product in the country early 2017. We look forward to updating the market in due course on the myLotus launch into China and our on-going developments in the UK and Europe as we target the product launch into our second international market towards the end of 2017."

 

 

ENDS

 

Enquiries:

The Company

Adam Reynolds, Chairman

Tel: +44 (0) 7785 908158

 

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin/Mark Brady

Tel: +44 (0)20 368 3550

 

Beaufort Securities Limited (Broker)

Jon Belliss

Tel: +44 (0)20 7382 8300

 

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles/ Joe Burgess

Tel: +44 (0) 7748 843 871

 

About Concepta Plc:

Concepta plc is a pioneering UK healthcare company that has developed a proprietary platform and products targeted at the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility*.

 

Founded in 2013, Concepta has developed a revolutionary flagship product 'myLotus' for home self-testing that helps women with unexplained infertility to conceive.

 

myLotus is the only consumer product which allows both quantitative and qualitative measurements of measurement of a woman's personal hCG and LH hormone levels in an easy to use home test to facilitate higher conception rates and early diagnosis of any fertility problems. Competitor products currently only allow qualitative measurement and are based on the 'average woman'.

 

Concepta has a defined route to market for its new 'my Lotus' product with Regulatory approvals for launch in China in place for 2016 and CE-Marking for UK and Europe to follow in 2017 where the revenue potential of the Chinese and EU infertility market is worth c.£600m per annum for the company.

 

*Unexplained infertility refers to women that have been unable to conceive after 6 months of trying. This highly motivated target group of consumers won't typically be offered medical intervention until 12 months of unsuccessfully trying, with IVF not offered until two years. Research indicates couples start to take positive action ahead of this time and there is little medical support to help them do so.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAQVLBBQLFXFBX
Date   Source Headline
27th Sep 20187:00 amRNSInterim Results
21st Sep 20189:47 amRNSHolding(s) in Company
28th Aug 20187:00 amRNSHolding(s) in Company
13th Aug 201812:55 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSHolding(s) in Company
9th Aug 201812:15 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSOversubscribed placing raises £2,000,000
17th Jul 20187:00 amRNSBoard Changes
14th Jun 201810:22 amRNSResult of AGM
22nd May 20185:13 pmRNSNotice of AGM
1st May 20187:00 amRNSFinal Results
26th Apr 201810:00 amRNSLogistics deal with major Chinese player SinoPharm
9th Apr 20188:25 amRNSConcepta manufacturing site achieves certification
29th Mar 20187:00 amRNSConcepta pre-launch myLotus in the UK
8th Mar 20187:00 amRNSmyLotus obtains approval to commence trial in UK
20th Feb 20187:00 amRNSLaunch of myLotus app in China
16th Feb 20187:00 amRNSTwo Senior Appointments and Grant of Options
15th Feb 20187:00 amRNSConcepta signs marketing contract in China
2nd Feb 20184:17 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSResults of Chinese hospital evaluations of myLotus
2nd Jan 201812:52 pmRNSChange of Broker
22nd Dec 201711:30 amRNSTrading update
14th Dec 20177:00 amRNSAssembly held in Shanghai to showcase myLotus
30th Nov 20173:05 pmRNSDirector/PDMR Shareholding
29th Nov 20179:02 amRNSHolding(s) in Company
13th Nov 20177:02 amRNSAppointment of Joint Corporate Broker
13th Nov 20177:01 amRNSOversubscribed equity fundraising of £2,000,000
13th Nov 20177:00 amRNSSales Order
6th Nov 201712:53 pmRNSTrading and Order Update
16th Oct 20177:00 amRNSmyLotus Fertility Product - China Update
19th Sep 20177:00 amRNSInterim Results
23rd Aug 201712:00 pmRNSCorporate Update
26th Jun 20177:00 amRNSDirector Shareholding
14th Jun 201712:00 pmRNSResult of AGM
13th Jun 20177:00 amRNSFirst Sales Order China and Trading Update
24th May 20174:58 pmRNSNotice of AGM
10th May 20177:00 amRNSFirst distributor agreement in China
26th Apr 20177:00 amRNSFinal Results
29th Mar 201710:00 amRNSUK Investor Show 2017
28th Mar 20177:00 amRNSDirectorate Changes
14th Feb 20171:45 pmRNSChange of Registered Office
7th Feb 20177:00 amRNSConcepta signs agreement with Selective Antibodies
9th Jan 20177:00 amRNSConcepta achieves ISO13485 accreditation
8th Dec 20167:00 amRNSAppointment China Country Manager
8th Nov 20167:09 amRNSNew manufacturing facility in Doncaster
10th Oct 20163:53 pmRNSIssue of Equity
26th Sep 20167:00 amRNSChinese Manufacturing Agreement Signed
21st Sep 20167:00 amRNSNew Laboratory Opening
18th Aug 20167:00 amRNSInterim Results
27th Jul 20164:11 pmRNSTR-1: Notification of major interest in shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.